(Q34030132)

30 July 2017

1 reference

title

Clopidogrel: a review of its use in the prevention of atherothrombosis (English)

1 reference

30 July 2017

1 reference

1 reference

B Jarvis

1

1 reference

PubMed ID

10983738

30 July 2017

K Simpson

series ordinal

2

1 reference

30 July 2017

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

60

1 reference

30 July 2017

2

1 reference

30 July 2017

347-377

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060020-00012

30 July 2017

0 references

cites work

Ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060020-00012

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060020-00012

Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060020-00012

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060020-00012

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200060020-00012

Pharmacokinetic profile of 14C-labeled clopidogrel

21 January 2018

1 reference

12 December 2020

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy for ischemic stroke

1 reference

12 December 2020

Ticlopidine-associated aplastic anemia. A case report and review of literature

1 reference

12 December 2020

1 reference

12 December 2020

Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

12 December 2020

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

12 December 2020

Antithrombotic therapy in peripheral arterial occlusive disease

1 reference

12 December 2020

Evidence for the existence of two different ADP-binding sites on rat platelets.

1 reference

12 December 2020

Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates

1 reference

12 December 2020

Prolonged heparin administration during clopidogrel treatment in healthy subjects

1 reference

12 December 2020

The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit

1 reference

12 December 2020

Effect of various antiplatelet agents on acute arterial thrombosis in the rat

1 reference

12 December 2020

Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers

1 reference

12 December 2020

ABC of arterial and venous disease: Chronic lower limb ischaemia

1 reference

12 December 2020

Clopidogrel does not affect the pharmacokinetics of theophylline

1 reference

12 December 2020

Antithrombotic agents in coronary artery disease

1 reference

12 December 2020

Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators

1 reference

12 December 2020

Improved clinical outcome after widespread use of coronary-artery stenting in Canada

1 reference

12 December 2020

Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions

1 reference

12 December 2020

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation

1 reference

12 December 2020

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity.

1 reference

12 December 2020

Repeated-dose pharmacodynamics of clopidogrel in healthy subjects

1 reference

12 December 2020

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

12 December 2020

ADP plays a key role in thrombogenesis in rats

1 reference

12 December 2020

The basic pharmacology of ticlopidine and clopidogrel

1 reference

12 December 2020

Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial

1 reference

12 December 2020

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

1 reference

12 December 2020

Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel

1 reference

12 December 2020

Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

1 reference

12 December 2020

ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel

1 reference

12 December 2020

Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association

1 reference

12 December 2020

Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets

1 reference

12 December 2020

Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?

1 reference

12 December 2020

Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro

1 reference

12 December 2020

Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients

1 reference

12 December 2020

Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel

1 reference

12 December 2020

Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events

1 reference

12 December 2020

Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting

1 reference

12 December 2020

Taming platelets in coronary stenting: ticlopidine out, clopidogrel in?

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.

1 reference

12 December 2020

Pharmacokinetics of clopidogrel

1 reference

12 December 2020

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets

1 reference

12 December 2020

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

12 December 2020

Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine

1 reference

12 December 2020

Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A

1 reference

12 December 2020

Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting

1 reference

12 December 2020

Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group

1 reference

12 December 2020

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

12 December 2020

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

1 reference

12 December 2020

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents

1 reference

12 December 2020

Aspirin versus clopidogrel: the wrong question?

1 reference

12 December 2020

Clopidogrel bioavailability: absence of influence of food or antacids.

1 reference

12 December 2020

Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting

1 reference

12 December 2020

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group

1 reference

12 December 2020

Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis

1 reference

12 December 2020

Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients

1 reference

12 December 2020

Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist

1 reference

12 December 2020

Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events

1 reference

12 December 2020

Aspirin therapy in diabetes

1 reference

12 December 2020

Clopidogrel Activities in Patients with Renal Function Impairment

1 reference

12 December 2020

Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat

1 reference

12 December 2020

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

1 reference

12 December 2020

Importance of platelets in experimental venous thrombosis in the rat.

1 reference

12 December 2020

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

1 reference

12 December 2020

1 reference

12 December 2020

Using patent foramen ovale (PFO) for percutaneous balloon mitral valvuloplasty

1 reference

12 December 2020

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation

1 reference

12 December 2020

A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery

1 reference

12 December 2020

ABC of arterial and venous disease. Secondary prevention of transient ischaemic attack and stroke

1 reference

12 December 2020

Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects

1 reference

12 December 2020

Secondary Prevention for Stroke after CAPRIE and ESPS-2

1 reference

12 December 2020

Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel

1 reference

12 December 2020

Stroke in patients with heart failure and reduced left ventricular ejection fraction

1 reference

12 December 2020

Blood dycrasias and hematologic reactions in ticlopidine users

1 reference

12 December 2020

Clopidogrel associated with acute arthritis

1 reference

12 December 2020

Results of coronary stenting for restenosis

1 reference

12 December 2020

Clinical aspects of the use of clopidogrel, a new antiplatelet agent

1 reference

12 December 2020

Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers

1 reference

12 December 2020

Cirrhosis does not affect the pharmacokinetics and pharmacodynamics of clopidogrel

1 reference

12 December 2020

Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits

1 reference

12 December 2020

Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems

1 reference

12 December 2020

ADP receptors on platelets and ADP-selective antiaggregating agents

1 reference

12 December 2020

The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel

1 reference

12 December 2020

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial

1 reference

12 December 2020

Single-dose pharmacodynamics of clopidogrel.

1 reference

12 December 2020

Secondary prevention for stroke after CAPRIE and ESPS-2. Opinion 2

1 reference

12 December 2020

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A

1 reference

12 December 2020

Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis

1 reference

12 December 2020

Use of clopidrogel in coronary stenting: what was the question?

1 reference

12 December 2020

Clopidogrel, a novel antiplatelet agent, and digoxin: absence of pharmacodynamic and pharmacokinetic interaction

1 reference

12 December 2020

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

12 December 2020

Role of P2Y1 purinoceptor in ADP-induced platelet activation

1 reference

12 December 2020

Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction

1 reference

12 December 2020

Clopidogrel: the future choice for preventing platelet activation during coronary stenting?

1 reference

12 December 2020

Clopidogrel versus ticlopidine after intracoronary stent placement

1 reference

12 December 2020

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

1 reference

12 December 2020

ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease.

1 reference

12 December 2020

10.2165/00003495-200060020-00012

Identifiers

DOI

1 reference

PubMed ID

10983738

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10983738